Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 1943918, 9 pages
http://dx.doi.org/10.1155/2016/1943918
Research Article

Diabetes-Induced Oxidative Stress in Endothelial Progenitor Cells May Be Sustained by a Positive Feedback Loop Involving High Mobility Group Box-1

Department of Cardiology, Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, China

Received 20 July 2015; Revised 24 September 2015; Accepted 28 September 2015

Academic Editor: Umesh Yadav

Copyright © 2016 Han Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K.-A. Kim, Y.-J. Shin, J.-H. Kim et al., “Dysfunction of endothelial progenitor cells under diabetic conditions and its underlying mechanisms,” Archives of Pharmacal Research, vol. 35, no. 2, pp. 223–234, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Tousoulis, N. Papageorgiou, E. Androulakis et al., “Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches,” Journal of the American College of Cardiology, vol. 62, no. 8, pp. 667–676, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Alev, M. Ii, and T. Asahara, “Endothelial progenitor cells: a novel tool for the therapy of ischemic diseases,” Antioxidants and Redox Signaling, vol. 15, no. 4, pp. 949–965, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Georgescu, N. Alexandru, A. Constantinescu, I. Titorencu, and D. Popov, “The promise of EPC-based therapies on vascular dysfunction in diabetes,” European Journal of Pharmacology, vol. 669, no. 1–3, pp. 1–6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. C. J. M. Loomans, E. J. P. De Koning, F. J. T. Staal et al., “Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes,” Diabetes, vol. 53, no. 1, pp. 195–199, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. N. António, R. Fernandes, A. Soares et al., “Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum,” Cardiovascular Diabetology, vol. 13, no. 1, article 101, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Maiese, “New insights for oxidative stress and diabetes mellitus,” Oxidative Medicine and Cellular Longevity, vol. 2015, 17 pages, 2015. View at Publisher · View at Google Scholar
  8. C. J. M. Loomans, E. J. P. De Koning, F. J. T. Staal, T. J. Rabelink, and A.-J. Van Zonneveld, “Endothelial progenitor cell dysfunction in type 1 diabetes: another consequence of oxidative stress?” Antioxidants and Redox Signaling, vol. 7, no. 11-12, pp. 1468–1475, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. G. P. Fadini, D. Losordo, and S. Dimmeler, “Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use,” Circulation Research, vol. 110, no. 4, pp. 624–637, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. V. L. Bodiga, S. R. Eda, and S. Bodiga, “Advanced glycation end products: role in pathology of diabetic cardiomyopathy,” Heart Failure Reviews, vol. 19, no. 1, pp. 49–63, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. E. Cooper, “Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease,” American Journal of Hypertension, vol. 17, no. 12, part 2, pp. 31S–38S, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. N. M. J. Hanssen, J. W. J. Beulens, S. Van Dieren et al., “Plasma advanced glycation end products are associated with incident cardiovascularevents in individuals with type 2 diabetes: a Case-Cohort study with a median follow-Up of 10 years (EPIC-NL),” Diabetes, vol. 64, no. 1, pp. 257–265, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Chen, M. Song, S. Yu et al., “Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress,” Molecular and Cellular Biochemistry, vol. 335, no. 1-2, pp. 137–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. Chen, L. Dong, L. Wang, L. Kang, and B. Xu, “Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2,” Biochemical and Biophysical Research Communications, vol. 381, no. 2, pp. 192–197, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Yu, D. Tang, and R. Kang, “Oxidative stress-mediated HMGB1 biology,” Frontiers in Physiology, vol. 6, article 93, 2015. View at Publisher · View at Google Scholar
  16. C. Zhang, M. Mo, W. Ding et al., “High-mobility group box 1 (HMGB1) impaired cardiac excitation-contraction coupling by enhancing the sarcoplasmic reticulum (SR) Ca2+ leak through TLR4-ROS signaling in cardiomyocytes,” Journal of Molecular and Cellular Cardiology, vol. 74, pp. 260–273, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. S. E. Hermansen, T. Lund, T. Kalstad, K. Ytrehus, and T. Myrmel, “Adrenomedullin augments the angiogenic potential of late outgrowth endothelial progenitor cells,” The American Journal of Physiology—Cell Physiology, vol. 300, no. 4, pp. C783–C791, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Yamashita, K. Nishihira, Y. Matsuura et al., “Paucity of CD34-positive cells and increased expression of high-mobility group box 1 in coronary thrombus with type 2 diabetes mellitus,” Atherosclerosis, vol. 224, no. 2, pp. 511–514, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Delucchi, R. Berni, C. Frati et al., “Resveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-functional ventricular remodeling in type-1 diabetic rats,” PLoS ONE, vol. 7, no. 6, Article ID e39836, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Škrha, M. Kalousová, J. Švarcová et al., “Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus,” Experimental and Clinical Endocrinology and Diabetes, vol. 120, no. 5, pp. 277–281, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Wang, H. Qu, and H. Deng, “Plasma HMGB-1 levels in subjects with obesity and type 2 diabetes: a cross-sectional study in China,” PLOS ONE, vol. 10, no. 8, Article ID e0136564, 2015. View at Publisher · View at Google Scholar
  22. D. Yao and M. Brownlee, “Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands,” Diabetes, vol. 59, no. 1, pp. 249–255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Wang, J. Shan, W. Yang, H. Zheng, and S. Xue, “High mobility group box 1 (HMGB1) mediates high-glucose-induced calcification in vascular smooth muscle cells of saphenous veins,” Inflammation, vol. 36, no. 6, pp. 1592–1604, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. W.-K. Wang, Q.-H. Lu, J.-N. Zhang et al., “HMGB1 mediates hyperglycaemia-induced cardiomyocyte apoptosis via ERK/Ets-1 signalling pathway,” Journal of Cellular and Molecular Medicine, vol. 18, no. 11, pp. 2311–2320, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Maugeri, P. Rovere-Querini, M. Baldini et al., “Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis,” Antioxidants & Redox Signaling, vol. 20, no. 7, pp. 1060–1074, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Xu, Y. Lu, J. Yao et al., “Novel role of resveratrol: suppression of high-mobility group protein box 1 nucleocytoplasmic translocation by the upregulation of sirtuin 1 in sepsis-induced liver injury,” Shock, vol. 42, no. 5, pp. 440–447, 2014. View at Publisher · View at Google Scholar
  27. S. Hamed, B. Brenner, A. Aharon, D. Daoud, and A. Roguin, “Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus,” Cardiovascular Diabetology, vol. 8, article 56, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Kalousová and T. Zima, “AGEs and RAGE—advanced glycation end-products and their receptor in questions and answers,” Vnitrni Lekarstvi, vol. 60, no. 9, pp. 720–724, 2014. View at Google Scholar · View at Scopus
  29. J. Chen, L. Huang, M. Song, S. Yu, P. Gao, and J. Jing, “C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells,” Journal of Cardiovascular Pharmacology, vol. 53, no. 5, pp. 359–367, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Feng, M. Zhu, M. Zhang et al., “Amelioration of compound 4,4′-diphenylmethane-bis(methyl)carbamate on high mobility group box1-mediated inflammation and oxidant stress responses in human umbilical vein endothelial cells via RAGE/ERK1/2/NF-κB pathway,” International Immunopharmacology, vol. 15, no. 2, pp. 206–216, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Vikram, Y.-R. Kim, S. Kumar et al., “Canonical Wnt signaling induces vascular endothelial dysfunction via p66Shc-regulated reactive oxygen species,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 10, pp. 2301–2309, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Zhou, H.-Z. Chen, Y.-Z. Wan et al., “Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction,” Circulation Research, vol. 109, no. 6, pp. 639–648, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Di Stefano, C. Cencioni, G. Zaccagnini, A. Magenta, M. C. Capogrossi, and F. Martelli, “P66ShcA modulates oxidative stress and survival of endothelial progenitor cells in response to high glucose,” Cardiovascular Research, vol. 82, no. 3, pp. 421–429, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Li, X. Zhang, X. Guan et al., “Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells,” Cardiovascular Diabetology, vol. 11, article 46, 2012. View at Publisher · View at Google Scholar · View at Scopus